Chung-Tsen Hsueh, Loma Linda University
Delong Liu, New York Medical College
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Editors-in-Chief
Articles
-
-
Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma
-
Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcome
-
The emerging landscape of circular RNAs in immunity: breakthroughs and challenges
-
Role of DNA repair defects in predicting immunotherapy response
-
The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer
-
Metabolomic analyses for atherosclerosis, diabetes, and obesity
-
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases
-
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
-
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
Aims and scope
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. Read more.
Announcing the launch of In Review
Biomarker Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Follow
Annual Journal Metrics
-
Speed
27 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
76 days from submission to acceptance
18 days from acceptance to publicationCitation Impact
4.866 - 2-year Impact Factor
1.068 - Source Normalized Impact per Paper (SNIP)
1.298 - SCImago Journal Rank (SJR)
Usage
151,831 Downloads
51 Altmetric mentions
On the blog
-
Looking beyond physical health for World Cancer Day 2020
24 January 2020
-
Breast Cancer Quiz 2019
30 September 2019
-
Sharing data for the benefit of children with cancer
09 September 2019
